BRETYLIUM TOSYLATE IN DEXTROSE 5% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bretylium Tosylate In Dextrose 5%, and when can generic versions of Bretylium Tosylate In Dextrose 5% launch?
Bretylium Tosylate In Dextrose 5% is a drug marketed by Abbott, B Braun, Baxter Hlthcare, and Hospira Inc. and is included in four NDAs.
The generic ingredient in BRETYLIUM TOSYLATE IN DEXTROSE 5% is bretylium tosylate. There are three drug master file entries for this compound. Additional details are available on the bretylium tosylate profile page.
Summary for BRETYLIUM TOSYLATE IN DEXTROSE 5%
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 41 |
DailyMed Link: | BRETYLIUM TOSYLATE IN DEXTROSE 5% at DailyMed |